Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials

Detalles Bibliográficos
Autores principales: Nelson, M, Amaya, G, Clumeck, N, Arns Da Cunha, C, Jayaweera, D, Junod, P, Taisheng, L, Tebas, P, Stevens, M, Buelens, A, Vanveggel, S, Boven, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112995/
http://dx.doi.org/10.1186/1758-2652-13-S4-P210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112995/
http://dx.doi.org/10.1186/1758-2652-13-S4-P210

Ejemplares similares